IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.183
NA - Nord America 3.130
EU - Europa 1.330
SA - Sud America 388
AF - Africa 60
OC - Oceania 16
AN - Antartide 1
Totale 12.108
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.025
US - Stati Uniti d'America 2.990
CN - Cina 1.009
IT - Italia 661
HK - Hong Kong 584
BR - Brasile 277
FR - Francia 176
VN - Vietnam 156
GB - Regno Unito 144
BD - Bangladesh 137
DE - Germania 94
IN - India 80
CA - Canada 65
NL - Olanda 53
AR - Argentina 44
MX - Messico 41
ID - Indonesia 32
TR - Turchia 28
JP - Giappone 26
FI - Finlandia 25
RU - Federazione Russa 24
CZ - Repubblica Ceca 20
CO - Colombia 17
ES - Italia 17
PL - Polonia 16
SA - Arabia Saudita 16
UA - Ucraina 16
ZA - Sudafrica 16
AU - Australia 15
CR - Costa Rica 12
SE - Svezia 12
AT - Austria 11
EC - Ecuador 11
PY - Paraguay 10
EE - Estonia 9
IQ - Iraq 9
JM - Giamaica 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
PE - Perù 8
TN - Tunisia 8
VE - Venezuela 8
BH - Bahrain 7
KR - Corea 7
MA - Marocco 7
MD - Moldavia 7
MY - Malesia 7
DZ - Algeria 6
LT - Lituania 6
PH - Filippine 6
EG - Egitto 5
NP - Nepal 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
BE - Belgio 4
GR - Grecia 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
Totale 12.091
Salva come PNG Salva come JPEG
Città #
San Jose 992
Singapore 665
Ashburn 662
Hong Kong 583
Rome 437
Hefei 331
Beijing 274
Dallas 238
Boardman 174
Lauterbourg 149
London 117
Shanghai 114
Santa Clara 78
Los Angeles 65
Ho Chi Minh City 51
New York 49
Council Bluffs 44
San Francisco 41
Munich 40
Hanoi 36
Amsterdam 31
São Paulo 30
Mexico City 27
Pune 25
Toronto 24
Brooklyn 23
Orem 22
Brno 19
Seattle 18
Chicago 16
Redmond 16
Montreal 15
Helsinki 14
Tokyo 14
Washington 14
Milan 13
Warsaw 12
Frankfurt am Main 11
Las Vegas 11
San José 11
Chennai 10
Haiphong 10
Stockholm 10
Turku 10
Ankara 9
Hyderabad 9
Riyadh 9
Tashkent 9
Xi'an 9
Boston 8
Melbourne 8
Naples 8
Phoenix 8
Biên Hòa 7
Johannesburg 7
Manchester 7
Ribeirão Preto 7
Atlanta 6
Bologna 6
Canberra 6
Charlotte 6
Curitiba 6
Denver 6
Hangzhou 6
Moscow 6
Paris 6
Rio de Janeiro 6
Asunción 5
Belo Horizonte 5
Buenos Aires 5
Campinas 5
Hamad Town 5
Kingston 5
Miami 5
Mumbai 5
New Delhi 5
Yeonsu-gu 5
Athens 4
Bauru 4
Buffalo 4
Capaccio 4
Da Nang 4
Genoa 4
Ha Long 4
Jakarta 4
Jeddah 4
Nairobi 4
Ninh Bình 4
Nuremberg 4
Oklahoma City 4
Padova 4
Philadelphia 4
Porto 4
Quito 4
Sona 4
Trieste 4
Vienna 4
West Jordan 4
Amman 3
Baghdad 3
Totale 5.851
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 300
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 257
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 248
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 248
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 241
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 237
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 233
Designing a broad-spectrum integrative approach for cancer prevention and treatment 233
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 231
Premetastatic niche: ready for new therapeutic interventions? 218
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 196
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 191
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 164
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 157
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 153
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 146
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 132
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 132
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 131
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 130
Anterior and posterior vaginal myomectomy: A new surgical technique 128
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 127
Biological effects of cabozantinib on bone microenvironment 126
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 126
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 125
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 125
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 123
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 121
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 119
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 119
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 118
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 117
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 116
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 116
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 115
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 104
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 99
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 91
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 85
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 84
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 82
MicroRNAs and bone metastasis: a new challenge 77
Molecular prognostic factors in patients with pancreatic cancer 75
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 69
New targets, new drugs for metastatic bone pain: a new philosophy 64
CETUXIMAB: From bench to bedside 63
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 62
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 62
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 60
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 59
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 59
Denosumab for cancer-related bone loss 58
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 58
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 57
The role of bone microenvironment, vitamin D and calcium 56
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 56
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 56
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 55
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation 55
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 54
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 54
Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7) 53
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 52
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 52
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 52
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence 52
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 52
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 52
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 52
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 51
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 51
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 51
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 50
New Technologies to Study the Interplay between Cancer Stem Cells and the Immune System 50
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 50
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 49
Epidemiologia e caratteristiche delle metastasi ossee 49
Prognostic and predictive factors in pancreatic cancer 49
Network approach in liquidomics landscape 49
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 48
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 48
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) 48
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 47
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 47
Targeting bone metastases starting from the preneoplastic niche: home sweet home 47
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 47
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 47
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) 46
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 46
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 46
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 46
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 46
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting 46
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature 45
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 45
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 45
Clinical performance of implanted devices used in surgical treatment of patients with spinal tumors: a systematic review 45
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 44
Totale 9.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/20265.527 484 226 397 511 249 349 1.457 401 454 539 273 187
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 12.245